MoneyWorks4Me

Shilpa Medicare informs about analyst meet

20 Jun 2025 Evaluate
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, as amended from time to time (Listing Regulations), Shilpa Medicare has informed that the official(s) of the Company will be meeting certain Investors/Analysts (Participants) as on 25th June 2025.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..